Anuh Pharma Limited — Others, 06-06-2025: Shareholders meeting

Anuh Pharma has announced a postal ballot seeking shareholder approval to issue bonus shares in a 1:1 ratio, effectively doubling the paid-up equity capital by capitalizing up to ₹25.06 Cr from reserves and retained earnings. This follows the commissioning and commercial operation of their new API-3 Plant, which is expected to enhance turnover and profitability. Bonus shares will be issued in dematerialized form, with physical shareholders’ shares credited to a demat suspense account until demat details are updated. This move rewards shareholders by sharing accumulated reserves.